Keurig Dr Pepper (NYSE:KDP) Upgraded at BMO Capital Markets

Keurig Dr Pepper (NYSE:KDP) was upgraded by research analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a research note issued on Monday, June 17th, Marketbeat Ratings reports. The firm presently has a $34.00 price objective on the stock, up from their prior price objective of $27.00. BMO Capital Markets’ target price indicates a potential upside of 17.08% from the stock’s current price.

KDP has been the subject of several other reports. ValuEngine upgraded Zynga from a “buy” rating to a “strong-buy” rating in a research report on Thursday, February 28th. Morgan Stanley set a €37.50 ($43.60) target price on shares of Deutsche Post and gave the stock a “buy” rating in a research note on Thursday, April 11th. Finally, Barclays reaffirmed a “hold” rating and issued a $52.00 target price on shares of Biohaven Pharmaceutical in a research note on Tuesday, March 19th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $28.95.

KDP traded down $0.12 during trading on Monday, reaching $29.04. The company’s stock had a trading volume of 1,323,700 shares, compared to its average volume of 2,547,618. The firm has a fifty day moving average of $29.17. Keurig Dr Pepper has a 52-week low of $22.19 and a 52-week high of $31.06. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.32 and a quick ratio of 0.23. The company has a market capitalization of $41.44 billion, a P/E ratio of 27.92, a price-to-earnings-growth ratio of 1.61 and a beta of 0.46.

Keurig Dr Pepper (NYSE:KDP) last posted its quarterly earnings results on Thursday, May 9th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.23 by $0.02. Keurig Dr Pepper had a net margin of 9.39% and a return on equity of 8.95%. The company had revenue of $2.50 billion during the quarter, compared to the consensus estimate of $2.54 billion. Keurig Dr Pepper’s revenue was up 164.1% on a year-over-year basis. As a group, research analysts anticipate that Keurig Dr Pepper will post 1.22 EPS for the current year.

In related news, Director Robert S. Singer acquired 2,000 shares of the stock in a transaction dated Friday, May 24th. The stock was bought at an average cost of $28.98 per share, with a total value of $57,960.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Holdings B.V. Maple sold 52,902,300 shares of the business’s stock in a transaction on Friday, May 17th. The shares were sold at an average price of $27.77, for a total transaction of $1,469,096,871.00. The disclosure for this sale can be found here. 0.44% of the stock is owned by insiders.

Institutional investors have recently made changes to their positions in the stock. GWM Advisors LLC purchased a new stake in Keurig Dr Pepper during the 1st quarter worth $31,000. Versant Capital Management Inc boosted its position in Keurig Dr Pepper by 751.3% during the 1st quarter. Versant Capital Management Inc now owns 1,328 shares of the company’s stock worth $37,000 after purchasing an additional 1,172 shares during the period. Penserra Capital Management LLC purchased a new stake in Keurig Dr Pepper during the 1st quarter worth $40,000. Trust Co. of Vermont boosted its position in Keurig Dr Pepper by 177.8% during the 1st quarter. Trust Co. of Vermont now owns 1,500 shares of the company’s stock worth $42,000 after purchasing an additional 960 shares during the period. Finally, CENTRAL TRUST Co boosted its position in Keurig Dr Pepper by 3,634.0% during the 1st quarter. CENTRAL TRUST Co now owns 1,755 shares of the company’s stock worth $49,000 after purchasing an additional 1,708 shares during the period. 14.27% of the stock is owned by hedge funds and other institutional investors.

About Keurig Dr Pepper

Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.

Recommended Story: What Are Treasury Bonds?

Analyst Recommendations for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.